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Introduction
Patellofemoral pain (PFP) is a common knee disorder in 
active young individuals comprising pain in and around 
the kneecap. Symptoms commonly occur during knee 
loading activities, such as running and stair climbing, and 
during sitting with the knees bent (1). Despite of a variety 
of treatment options, such as exercise therapy, patellar 
taping/bracing and foot orthoses, a large group of patients 
with persistent complaints remains (2-5). PFP has been 
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implicated as precursor of knee osteoarthritis (OA), but the 
exact pathophysiology remains unknown (6-8).
Pathophysiologic processes of the infrapatellar fat pad 
(IPFP), also known as ‘Hoffa’s fat pad’, have been proposed 
as a possible source of knee pain (9-13). The IPFP is a richly 
innervated, highly vascularized, intracapsular, extra-synovial 
structure in the anterior knee joint between the patella 
and femur, where it plays a biomechanical role (12,14-16). 
Structural changes of the IPFP, for example focal IPFP 
edema as sign of inflammation, have been pinpointed as 
precursor for structural knee OA, and a larger IPFP size 
was found in patients with patellofemoral OA (PFOA) 
(17-19). IPFP size could increase as a result of low-grade 
inflammation due to repetitive mechanical overload, as for 
example in Hoffa disease (20) or, hypothetically, can also 
be larger to begin with and predispose to pain without any 
pathophysiologic cause. In a PFP population no differences 
in the presence of focal edema of the IPFP between healthy 
control subjects and patients with PFP was demonstrated (21). 
IPFP size has been studied in OA (17,22), but has not been 
studied in PFP yet. Besides the biomechanical role, it is also 
suggested that the IPFP is an osteoarthritic joint tissue capable 
of modulating inflammatory responses in knee OA (11). 
This might also apply to PFP.
Dynamic contrast-enhanced magnetic resonance imaging 
(DCE-MRI) enables non-invasive evaluation of inflammation 
by measuring blood perfusion, which is known to increase in 
the presence of inflammation. DCE-MRI derived increased 
blood perfusion parameters are therefore considered imaging 
biomarkers of inflammation in various musculoskeletal 
tissues (23-28). To our knowledge, only one prior study 
applied semi-quantitative DCE-MRI in the IPFP of obese 
patients with knee OA and showed a correlation between 
knee pain and inflammation (28). In a previous study 
including the same study population as the current study, 
quantitative DCE-MRI analysis of the patella identified 
an increased patellar perfusion, contrary to the decreased 
patellar perfusion based on vascular alterations that was 
expected (29). Among the potential explanations of increased 
perfusion is the occurrence of an inflammatory process in 
which the IPFP plays an important modulating role (12).
Therefore, the aim of this study was to compare 
quantitative DCE-MRI blood perfusion parameters, as 
imaging biomarkers of inflammation, and volume of the 
IPFP between patients with PFP and healthy control 
subjects. A second aim was to explore if specific perfusion 
patterns exist in patients based on correlation of DCE-
MRI perfusion parameters with clinical or MR imaging 
characteristics that potentially are related to inflammation 
or perfusion. Hypothetically, a larger IPFP volume and 
higher blood perfusion values are expected in patients with 
PFP than in healthy control subjects.
Methods
Study design and participants
In the current study, data was analyzed from a previously 
conducted cross sectional case-control study. Patients with 
minimum symptom duration of 2 months to a maximum 
of 2 years and healthy control subjects were included 
between January 2013 and September 2014. Patients who 
visited their general practitioner, physiotherapist or sports 
physician were included if diagnosed with PFP based on the 
presence of at least three of the following symptoms: pain 
while stair climbing; while squatting; while running; while 
cycling; while sitting for a prolonged period with the knee 
flexed, or crepitus. Exclusion criteria were: previous PFP 
episodes more than 2 years ago, onset after trauma, defined 
pathological condition of the affected knee at present, or 
previous surgery or injury of the affected knee. Healthy 
controls were recruited from patients’ sports team members, 
friends, or colleagues. Exclusion criteria of controls were: 
history of PFP, surgery or injury of both knees, or first-
degree relatedness with patients. Other exclusion criteria for 
both groups were: contra-indications for contrast-enhanced 
MRI and insufficient knowledge of the Dutch language. 
Patients and controls were aimed to match for age, gender, 
body mass index (BMI), and activity level. Full details of this 
study have been published elsewhere (21). This study was 
approved by our institutional review board, is conducted 
in accordance with the Helsinki Declaration and written 
informed consent was obtained from all participants. All 
patients and controls, aged 18–40 years, with DCE-MRI 
data available were included in the current analysis.
Image acquisition and measures
Participants underwent 3 Tesla MRI (Discovery MR750, 
GE Healthcare, USA) using a dedicated 8-channel knee 
coil (Invivo Inc., USA) at our institution. One knee, the 
(most) symptomatic knee of PFP patients was selected, 
or randomly chosen if both knees were equally painful or 
if both were asymptomatic (controls). The MRI protocol 
consisted of routine clinical proton density and T2-
weighted fat-saturated sequences in three orthogonal planes, 
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and a sagittal 3D non-fat-saturated fast-spoiled gradient-
echo (non-FS FSPGR) sequence with a slice thickness of 
0.5 mm.
DCE-MRI was acquired by a time-resolved imaging of 
contrast kinetics (TRICKS) sequence with anterior-posterior 
(AP) frequency encoding direction to avoid pulsation artifacts 
of the popliteal artery into the region of interest. MRI 
parameters were: in-plane pixel resolution 1.5 mm, slice 
thickness 5 mm, field of view 380×380×70 mm, acquisition 
matrix 256×128, 14 sagittal slices, 70% sampling in the phase 
direction, TE =1.7 ms, TR =9.3 ms, FA =30°. The DCE-
MRI protocol consisted of 35 phases of 10.30±0.07 s (constant 
within subject). Intravenous contrast administration of 
0.2 mmol/kg gadopentetate dimeglumine (Magnevist, Bayer, 
Berlin, Germany), at a rate of 2 mL/s, was started after the 
first phase. Additionally, a non-fat-suppressed 3D FSPGR 
sequence with in-plane resolution of 0.3 mm × 0.3 mm and 
0.5 mm slices was acquired before contrast administration for 
delineation of the patellar bone marrow.
In addition, participants completed a questionnaire 
on demographics, sports participation (yes/no) and knee 
complaints [Numerical Rating Score (NRS) pain score 
during rest and exercise, duration of symptoms, and 
function measured by the Anterior Knee Pain Scale (AKPS) 
0–100 (30)]. Finally, a physical examination was performed 
in which the pressure pain threshold at the contralateral 
arm was tested as a measure of pain sensitization, according 
to a prior published method (31,32).
Image analysis
IPFP edema located centrally and superolaterally and joint 
effusion were already assessed as part of the Magnetic 
Resonance Imaging Osteoarthritis Knee Score (MOAKS) 
with several additional scoring items in a prior study (21,33).
The volume of interest (VOI) consisted of the whole 
IPFP with the following boundaries according to a recent 
study: the inferior patellar pole, femoral intercondylar notch, 
proximal patellar tendon, intermeniscal ligament, both 
menisci and the anterior tibia (15). VOIs were delineated 
in correspondence with the DCE-MRI data on the non-
FS FSPGR sequence, which has previously been reported 
to be superior to fat-saturated images (Figure 1) (34). 
All VOIs were drawn by a senior radiology resident 
subspecializing in musculoskeletal imaging (RA van der 
Heijden) after careful consideration of the boundaries in 
the first 10 subjects together with a senior musculoskeletal 
radiologist (EHGO). DCE-MRI time points were 
registered using an automated rigid body registration with 
Elastix (35). Horos software (Horosproject.org, USA) was 
used to delineate the VOIs, register the non-FS FSPGR 
and DCE-maps, calculate the 3D volume and extract the 
perfusion parameters of the VOI with the DCE-tool (36). 
Fitting a pharmacokinetic model to the data enables 
extraction of quantitative DCE-MRI parameters which (to 
a greater or lesser extent) reflect physiological phenomena 
such as blood flow, blood volume, and extravascular 
permeability (37). Tofts’ pharmacokinetic model has shown 
to be the most accurate model for patellar bone (38). Tofts’ 
extended model is more suitable for highly vascularized 
structures, such as the IPFP, by adding the vascular term 
Vp (37). The arterial input function (AIF) was estimated 
in each participant using a ROI in the popliteal artery. All 
fitted AIF’s were visually checked. Quantitative DCE-MRI 
perfusion parameters Ktrans, Kep, Ve and Vp) were extracted 
by fitting the Tofts’ extended pharmacokinetic model 
(Figure 2) (39). Ktrans reflects the volume transfer constant 
into the tissue compartment, Kep describes the rate constant 
back into the vascular component, Ve the extravascular 
extracellular space and Vp the vascular fraction.
Statistical analysis
The Shapiro-Wilk test was used to evaluate normality of 
the distribution of the parameters. Independent sample 
t-tests and chi-square tests, or Mann-Whitney U tests if 
data distribution was not normal, were applied to investigate 
Figure 1 Delineation of the IPFP on the non-FS FSPGR sequence 
(red line). IPFP, infrapatellar fat pad; non-FS FSPGR, non-fat-
saturated fast-spoiled gradient-echo.
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differences in baseline characteristics between groups.
The DCE image analysis resulted in a mean value for 
the perfusion parameters within each VOI. The mean and 
standard deviation over all subjects were calculated for 
control subjects and PFP patients separately. Differences 
in variance of volume and perfusion parameters across 
subjects were tested with Levene’s test. Volume followed 
a normal distribution. All perfusion parameters showed 
a normal distribution of residuals after logarithmic 
transformation and, accordingly, regression analyses 
could be performed. Differences in volume and perfusion 
parameters between groups were compared by linear 
regression analyses, adjusted for age, gender, BMI, 
and sports participation. Furthermore, possible patient 
subgroups were explored by multivariate linear regression 
analysis of the following variables: pain during rest and 
during exercise, duration of complaints, presence of sitting 
pain, function, pain pressure threshold contralateral 
arm as sensitization measure, presence of IPFP edema 
centrally and superolaterally and joint effusion. P values 
<0.05 were considered to be statistically significant for the 
main linear regression analyses. Results are presented as 
mean differences with 95% confidence intervals. For the 
subgroup’ analyses, a lower P value of <0.01 was applied 
due to multiple testing. All analyses were performed with 
SPSS v25 (IBM, USA).
Results
Population and patient characteristics
In a prior study, 64 patients with PFP and 70 control 
subjects aged 14–40 years were included (Figure 3). DCE-
MRI was only acquired in adults and image quality was 
sufficient in 35 adults PFP patients and 44 adult control 
subjects. Mean age was 26.1 (range, 18–40, SD 5.0) years, 
mean BMI was 24.1 (SD, 3.4) kg/m2 and 49% (39) was 
female. The BMI was significantly higher in the patient 
group (Table 1). Patients reported a mean duration of 
complaints of 11.2 months and 45.7% (16) reported 
bilateral pain. Centrally located moderate to severe IPFP 
edema was present in one patient and two control subjects. 
Superolateral IPFP edema was present in 16 patients and 19 
control subjects. Medium to large effusion (corresponding 
with MOAKS grade 2–3) was present in four patients and 
seven control subjects. There were no significant differences 
in the presence of these features.
Volume and DCE-MRI parameters
Due to a lack of a plateau phase in the time intensity curve, 
the fitting algorithm might not provide valid values of Ve 
and subsequently Kep and therefore those parameters were 
not shown.
Mean IPFP volume was 26.04 (4.18) mL in control 
subjects and 27.52 (5.37) mL in patients. Median Ktrans 
was 0.017 (0.016) min–1 in control subjects and 0.016 
(0.020) min–1 in patients. Median Vp was remarkably higher 
in patients than control subjects, respectively 0.00037 
(0.00039) and 0.00029 (0.00033), but this difference was not 
statistically significant (P=0.10). Mean volume and perfusion 
parameters did not differ between groups (Table 2, Figure 3).
Vp was the only perfusion parameter for which Levene’s 
test showed a significant difference in variance across 
groups (P=0.035). Further visual inspection of the boxplots 
showed two outliers in the patient group, which most likely 
account for the difference in variance (Figure S1: boxplot 
without the largest patient outlier).
The patient subgroup analyses showed that presence 
of joint effusion was significantly associated with elevated 
Ktrans (P=0.002) and Vp (P=0.004), but not with volume 
(P=0.41). Remarkably, this association was not present in 
control subjects. None of the other subgroup analyses 
Figure 2 Overlay of a Ktrans map of the IPFP on the non-FS 
FSPGR sequence in a PFP patient. IPFP, infrapatellar fat pad; 
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revealed significant associations for respectively volume/
Ktrans/Vp: pain during rest P=0.76/0.74/0.31; during exercise 
P=0.07/0.25/0.51; duration of complaints P=0.78/0.30/0.14; 
presence of sitting pain P=0.29/0.23/0.24; function 
P=0.57/0.88/0.48; pain pressure threshold contralateral 
arm as sensitization measure P=0.82/0.54/0.27; presence of 
IPFP edema centrally P=0.11/0.44/0.56; presence of IPFP 
edema superolaterally P=0.82/0.75/0.54.
Discussion
In this study, volume and quantitative DCE-MRI 
blood perfusion parameters Ktrans and Vp of the IPFP 
were compared between healthy control subjects and 
patients with PFP. In contrast to our hypothesis, no 
significant differences were found in volume or DCE-
MR blood perfusion parameters, as imaging biomarkers of 
inflammation, of the IPFP between healthy control subjects 
and patients with PFP. Furthermore, patient subgroups 
were explored in search of an association of DCE-MRI 
parameters with clinical characteristics and MR features 
potentially related to volume or perfusion/inflammation. 
Only effusion was significantly associated with higher Ktrans 
and Vp in patients with PFP.
In recent studies, inconsistent results were found in OA 
populations regarding IPFP volume. One study found an 
association between a larger volume and fewer structural 
abnormalities in patients with clinical knee OA, suggesting 
a protective role of a larger IPFP (40). Two other studies 
did not find a correlation between IPFP volume and 
Figure 3 Boxplots of volume (mL) and perfusion parameters Ktrans (min
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symptomatic or radiographic knee OA (17,41). A fourth 
study, specifically focusing on PFOA, demonstrated that 
individuals with PFOA had a larger IPFP than controls, and 
a larger IPFP volume was directly related to pain (42) Since 
age presumably influences fat pad volume in patient with 
OA, the current volumes cannot be directly compared with 
the prior study including an older population of patients 
with PF OA (43).
The single prior study that applied DCE-MRI, in a 
semi-quantitative manner, to investigate IPFP inflammation 
found a relation between their perfusion derived 
inflammation marker and knee pain in obese patients with 
knee OA (28). DCE-MRI had not yet been applied in the 
IPFP of patients with PFP and healthy control subjects.
The lack of a difference between patients with PFP and 
control subjects might be explained by a still preserved 
tissue homeostasis in PFP without induced inflammatory 
response. In order to determine if a certain patient subgroup 
with explicit inflammation could be identified, additional 
exploratory subgroup analyses were conducted focusing 
on clinical characteristics and MR features potentially 
related inflammation. For instance, a larger size and higher 
Table 1 Characteristics of study participants
Characteristics Patients (n=35) Controls (n=44) P value
Female gender, n (%) 18 (51.4) 21 (47.7) 0.74
Age (years), mean (SD) 26.4 (5.6) 25.9 (4.6) 0.53
BMI (kg/m²), mean (SD) 25.1 (3.8) 23.3 (2.8) 0.01
Sports participants, n (%)
During inclusion 24 (68.6) 34 (77.3) 0.39
Before onset of pain 32 (91.4) NA NA
Pain (NRS), mean (SD)
During rest 3.9 (2.7) NA NA
During strain 6.3 (2.4) NA NA
Duration of complaints, mean (SD) 11.2 (6.3) NA NA
Bilateral pain, n (%) 16 (45.7) NA NA
Sitting pain, n (%) 27 (77.1) NA NA
AKP function score, mean (SD) 68.6 (11.0) NA NA
Pain pressure threshold arm, mean (SD) 50.3 (13.8) 56.1 (14.3) 0.07
IPFP edema central (moderate to severe), n (%) 1 (2.9) 2 (4.5) 0.59
IPFP edema superolateral, n (%) 16 (45.7) 19 (43,2) 0.50
Effusion (medium to large), n (%) 4 (11.4) 7 (15.9) 0.50
BMI, body mass index; NRS, Numerical Rating Score; AKP, Anterior Knee Pain; IPFP, infrapatellar fat pad.
Table 2 Mean (SD) of the volume and median (IQR) of the VOI mean for Ktrans and Vp and mean difference (95% CI) and adjusted P value in 
patients and controls
Measures Patients (n=35) Controls (n=44) Mean difference (95% CI) Adjusted P value
Volume (mL) 27.52 (5.37) 26.04 (4.18) 1.48 (–0.66, 3.62) 0.07
Ktrans (min
–1) 0.016 (0.020) 0.017 (0.016) –1.12 (–13.47, 11.21) 0.98
Vp 0.00037 (0.00039) 0.00029 (0.00033) 1.10 (–0.65, 2.85) 0.10
VOI, volume of interest.
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perfusion of the IPFP could be expected in patients with 
other proposed signs of inflammation, such as Hoffa edema 
or effusion. Furthermore, we hypothesized that low-grade 
inflammation resulting in higher perfusion and/or increased 
volume would be associated with more pain and worse 
function or would have a more systemic effect resulting 
in longer symptom duration or presence of sensitization. 
Finally, an increase in size or vascular changes could also 
have been the answer to the enigma of patients with PFP, 
which explicitly exhibit pain during sitting with the knees 
bent (29,44,45). In the end, none of these variables were 
significantly associated with volume or perfusion parameters 
besides effusion. Effusion was significantly associated with 
Ktrans and Vp. indicating a larger vascular fraction and more 
blood inflow in patients. Further evaluation revealed that 
these associations were not present in control subjects.
This implies that joint effusion is only associated with 
inflammation and neovascularization in patients with PFP. 
These results are only speculative, though, due to the low 
number of subjects per group. A potential explanation 
for the difference between groups might lie in a different 
mechanism of effusion, implying an inflammatory pathway 
in patients only. In control subjects one possible explanation 
might be a mechanical pathway.
In this study, for the first time, the IPFP volume and IPFP 
blood perfusion were quantitatively analyzed by DCE-MRI in 
order to unravel the role of the IPFP in the pathophysiology 
of PFP. A strength of this study is the inclusion of healthy 
control subjects next to patients with PFP. Furthermore, 
the current study applied quantitative assessment of DCE-
MRI perfusion values, which offers more robust parameters 
that directly represent the microvasculature physiology, in 
contrast to semi-quantitative analysis.
A potential limitation might be the lack of B1+ or pre-
contrast T1 map, which led to the use of a literature based 
fixed T1(0) value of 1,443 ms. We do not expect this to 
have affected the outcome, since no differences in native 
T1 variability were expected between groups. Furthermore, 
a dedicated transmit/receive knee coil with relatively 
homogeneous B1 field was used. Second, quality of DCE-
MRI imaging data was not sufficient in nine patients 
and six control subjects due to artifacts at the beginning 
of the study. We do not expect this to have influenced 
our conclusions, as the baseline characteristics of these 
participants did not differ from the participants in which 
the DCE-MRI was sufficient. Due to time constraints in 
our MR protocol, DCE-MRI acquisition did not last long 
enough for the time intensity curve to reach plateau phase. 
As this might potentially lead to unreliable estimates of Ve 
and subsequently also of Kep, only the robust parameters 
Ktrans and Vp were presented. This is sufficient for our 
research purpose as these two are the most important 
parameters to identify increased perfusion.
ROI delineation was done by a single observer only, 
which leaves the variability introduced by having an 
alternative observer unknown. A previous study stated 
that the inter-observer variability is low when a large 
ROI is used (46). This was done in quantitative MRI of 
cartilage, but given our experience in both cartilage and 
other structures like the fat pad we found these comparable. 
Furthermore, the boundaries of the ROI were discussed in 
depth with a senior musculoskeletal radiologist (EHGO).
Since a group-wise AIF is not available within the DCE-
tool, we used a subject-specific AIF, despite the probability 
of not capturing the arterial bolus given the low temporal 
resolution of 10 seconds. Therefore, all AIF curves were 
visually checked and appeared to capture the bolus peak 
adequately. Another point to notice is that small, yet 
significant differences could have been left undetected due 
to the large inter-subject variability. Power analysis was not 
feasible in advance, due to the lack of knowledge regarding 
effect sizes. In future research including a larger number of 
subjects would be advised in order to be able to draw firm 
conclusions. With regard to our results, we do not think this 
would affect the main outcome as inter-subject variability 
is equally present in both groups and the variance was not 
statistically significantly different between groups, except 
for Vp. The clinical relevance of these potentially missed 
small differences would also be questionable given the small 
effect sizes and the fact that patients had a lower mean of 
Ktrans and Vp, which does not concur with the suspected 
increased blood perfusion accompanying inflammation. 
Finally, some of the subgroup analyses were theoretically 
underpowered due to the low prevalence of features. If 
these would have been the key features for the incidence of 
PFP, though, a higher prevalence would have been expected 
to start with. In general, due to the cross-sectional design 
no causal relations could be studied, but only associations. 
Future research might try to achieve a complete picture 
of the perfusion in the knee joint. For now, this is quite 
challenging, because different tissues require different 
pharmacokinetic models.
In conclusion, patients with PFP and healthy control 
subjects do not demonstrate a significantly different volume 
or blood perfusion of the IPFP. Thus, it seems that higher 
IPFP blood perfusion measured by DCE-MRI, as imaging 
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biomarker of inflammation, and larger volume are not 
associated with PFP.
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Figure S1 Boxplot of Vp multiplied by 1,000 with exclusion of the biggest patient outlier. The * means the remaining outliers.
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